全球生物可吸收支架市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計生物可吸收支架市場將從 2025 年的 4.7312 億美元成長到 2034 年的 8.6035 億美元，2026 年至 2034 年的複合年成長率為 6.87%。

隨著醫療專業人員尋求治療心血管疾病的先進方案，生物可吸收支架的全球市場正在不斷擴大。生物可吸收支架是一種用於疏通阻塞動脈並隨時間推移在體內逐漸溶解的醫療設備。與傳統的金屬支架不同，這些裝置提供暫時的支撐，從而減少了與永久性植入相關的長期併發症。

多種因素正在推動生物可吸收支架市場的成長。心血管疾病的日益普遍以及對微創治療方法需求的不斷成長，正在促進創新支架技術的研發。生物可吸收支架在某些臨床應用中極具吸引力，因為它們具有在支架溶解後恢復血管自然功能的優勢。

隨著心血管器械研究的不斷深入，生物可吸收支架市場預計將持續成長。材料科學和支架設計的進步有望提升支架的安全性和有效性。隨著醫療專業人員尋求治療心臟病的先進方案，生物可吸收支架將在未來的心血管醫學中發揮至關重要的作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球生物可吸收支架市場：依生物材料分類

• 市場分析、洞察與預測
• 生物可吸收聚合物支架
• 生物可吸收金屬支架

第5章 全球生物可吸收支架市場：依應用分類

• 市場分析、洞察與預測
• 冠狀動脈疾病
• 周邊動脈疾病

第6章 全球生物可吸收支架市場：依吸收率分類

• 市場分析、洞察與預測
• 吸收速度慢
• 快速吸收率

第7章 全球生物可吸收支架市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 心臟中心
• 門診手術中心

第8章 全球生物可吸收支架市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Amaranth Medical
  • Arterial Remodeling Technologies
  • Arterius Limited
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Elixir Medical Corporation
  • Kyoto Medical Planning Co. Ltd
  • MicroPort Scientific Corporation
  • Reva Medical
  • Terumo Corporation

The Bioabsorbable Stents Market size is expected to reach USD 860.35 Million in 2034 from USD 473.12 Million (2025) growing at a CAGR of 6.87% during 2026-2034.

The global bioabsorbable stents market has grown as healthcare providers explore advanced solutions for treating cardiovascular diseases. Bioabsorbable stents are medical devices used to open blocked arteries and gradually dissolve in the body over time. Unlike traditional metal stents, these devices provide temporary support and reduce long-term complications associated with permanent implants.

Several factors are driving the growth of the bioabsorbable stents market. Increasing prevalence of cardiovascular diseases and growing demand for minimally invasive treatment options have encouraged the development of innovative stent technologies. Bioabsorbable stents offer the advantage of restoring natural vessel function after the device dissolves, making them attractive in certain clinical applications.

Looking ahead, the bioabsorbable stents market is expected to expand as research in cardiovascular devices continues to advance. Improvements in material science and stent design may enhance safety and effectiveness. As healthcare providers seek advanced solutions for heart disease treatment, bioabsorbable stents may play an important role in future cardiovascular care.

MARKET SEGMENTATION

By Biomaterial

• Bioabsorbable Polymer-based Stents
• Bioabsorbable Metallic Stents

By Application

• Coronary Artery Disease
• Peripheral Artery Disease

By Absorption Rate

• Slow Absorption Rate
• Fast Absorption Rate

By End User

• Hospitals
• Cardiac Centers
• Ambulatory Surgical Centers

COMPANIES PROFILED

• Amaranth Medical, Arterial Remodeling Technologies, Arterius Limited, B Braun Melsungen AG, Biotronik SE Co KG, Boston Scientific Corporation, Elixir Medical Corporation, Kyoto Medical Planning Co Ltd, MicroPort Scientific Corporation, Reva Medical, Terumo Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOABSORBABLE STENTS MARKET: BY BIOMATERIAL 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Biomaterial
• 4.2. Bioabsorbable Polymer-based Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Bioabsorbable Metallic Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOABSORBABLE STENTS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Coronary Artery Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Peripheral Artery Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOABSORBABLE STENTS MARKET: BY ABSORPTION RATE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Absorption Rate
• 6.2. Slow Absorption Rate Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Fast Absorption Rate Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOABSORBABLE STENTS MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Cardiac Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BIOABSORBABLE STENTS MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Biomaterial
  • 8.2.2 By Application
  • 8.2.3 By Absorption Rate
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Biomaterial
  • 8.3.2 By Application
  • 8.3.3 By Absorption Rate
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Biomaterial
  • 8.4.2 By Application
  • 8.4.3 By Absorption Rate
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Biomaterial
  • 8.5.2 By Application
  • 8.5.3 By Absorption Rate
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Biomaterial
  • 8.6.2 By Application
  • 8.6.3 By Absorption Rate
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BIOABSORBABLE STENTS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Amaranth Medical
  • 10.2.2 Arterial Remodeling Technologies
  • 10.2.3 Arterius Limited
  • 10.2.4 B. Braun Melsungen AG
  • 10.2.5 Biotronik SE & Co. KG
  • 10.2.6 Boston Scientific Corporation
  • 10.2.7 Elixir Medical Corporation
  • 10.2.8 Kyoto Medical Planning Co. Ltd
  • 10.2.9 MicroPort Scientific Corporation
  • 10.2.10 Reva Medical
  • 10.2.11 Terumo Corporation